Enhanced recovery (ERAS) after minimally invasive stomach cancer surgery
Official title: Effectiveness of Enhanced Recovery After Surgery (ERAS) on Postoperative Recovery After Minimally Invasive Gastrectomy: A Multi-center Open-labeled Randomized Controlled Study
Run by Seoul National University Hospital · NCT06984952 · Data updated 2026-11-12
This project tests whether an enhanced recovery (ERAS) program helps people recover faster and leave the hospital sooner after minimally invasive stomach cancer surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 308 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 10 sites (Busan and 9 other locations) |
| Status | Recruiting |
| Started | June 13, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | March 31, 2029 |
| Registry record updated | September 5, 2025 |
| Trial ID | NCT06984952 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 19 or older scheduled for elective laparoscopic or robotic gastrectomy for gastric cancer with ASA physical status I–III who can provide informed consent and complete patient-reported measures.
✕Probably not a fit
Patients who require additional organ resections, have prior upper abdominal surgery (other than cholecystectomy), or have known hypersensitivity to the study analgesics may not be eligible or likely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, randomized, open-label, multicenter trial compares a structured ERAS protocol with conventional perioperative care in adults undergoing elective laparoscopic or robotic gastrectomy for gastric cancer. Patients were randomized 1:1 (154 per group) to receive either the ERAS pathway or usual care, with ERAS elements including preoperative carbohydrate loading, shorter perioperative fasting, and multimodal opioid-sparing analgesia. The primary outcome is the proportion of patients who meet standardized discharge criteria at 9:00 AM on postoperative day 4, and secondary outcomes include EQ-5D-5L quality-of-life scores, pain at rest and with coughing, I-FEED gastrointestinal function, postoperative nausea and vomiting, major complications (Clavien-Dindo), and length of hospital stay. The open-label design and multiple high-volume centers aim to generate results that reflect real-world implementation of ERAS in minimally invasive gastrectomy.
Why it matters
Potential benefit: If successful, the ERAS protocol could let more patients meet discharge criteria earlier, reduce pain and nausea, and shorten hospital stays after minimally invasive gastrectomy.
How similar studies have gone: ERAS programs have improved recovery and shortened hospital stays in colorectal surgery and have shown benefit in several gastric surgery reports, although protocols and effect sizes vary across centers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged ≥19 years scheduled to undergo elective laparoscopic or robotic gastrectomy for gastric cancer * American Society of Anesthesiologists physical status classification I to III * Ability to provide written informed consent, demonstrate understanding of the study protocol, and complete patient-reported outcome measures appropriately Exclusion Criteria: * Requirement for resection of organs other than the stomach during surgery (except for cholecystectomy) * History of upper abdominal surgery (except for cholecystectomy) * Known hypersensitivity to fentanyl, ropivacaine, acetaminophen, or non-steroidal anti-inflammatory drugs * Determined by the investigator or study personnel to be otherwise unsuitable for participation in the study
Where it's running
-
Dongsan Hospital, Keimyung University School of Medicine
Daegu, South Korea Recruiting -
Seoul National University Hospital
Seoul, South Korea Recruiting -
Pusan National University Hospital
Busan, South Korea Not yet recruiting -
Chungnam National University Hospital
Daejeon, South Korea Not yet recruiting -
National Cancer Center
Goyang, South Korea Not yet recruiting -
Seoul National University Bundang Hospital
Seongnam, South Korea Not yet recruiting
Show 4 more locations
-
Seoul St. Mary's Hospital
Seoul, South Korea Not yet recruiting -
Severance hospital
Seoul, South Korea Not yet recruiting -
SMG-SNU Boramae Medical Center,
Seoul, South Korea Not yet recruiting -
Ajou University School of Medicine
Suwon, South Korea Not yet recruiting
Study contacts
- Principal investigator: Do Joong Park, MD, PhD — Seoul National University Hospital
- Study coordinator: Hojin Lee, MD, PhD
- Email: hjpainfree@snu.ac.kr
- Phone: 82-2-2072-2467
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tramadol vs Morphine for Postoperative Pain After Laparoscopic Abdominal Surgery
This study tests whether tramadol can provide comparable pain relief to morphine after laparoscopic abdominal surgery when used as part of multimodal pain management.
-
AI-guided reoperation decisions for bleeding after stomach cancer surgery
This project will test whether an AI model can predict serious postoperative bleeding and help doctors decide if and when to reoperate for adults after radical gastrectomy for gastric cancer.
-
Improving recovery after pancreatic surgery
This study is testing if a special recovery program can help people recover better and faster after surgery for pancreatic cancer compared to standard care.
-
Comparing early and late resumption of oral feeding after bowel surgery
This study tests whether starting to eat again within 24 hours after bowel surgery helps patients recover better than waiting 24 to 48 hours.
-
Using indocyanine green to improve lymph node removal in gastric cancer surgery
This study is testing if a special dye called indocyanine green can help surgeons find and remove more lymph nodes during gastric cancer surgery.
-
Evaluating a rapid recovery protocol for coronary artery bypass surgery
This study tests a new recovery plan for people having heart surgery to see if it helps them get better faster compared to the usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.